Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. - Broderick JP; Naidech AM; Elm JJ; Toyoda K; Dowlatshahi D; Demchuk AM; Khatri P; Steiner T; Bath PM; Audebert HJ; Vagal A; Yoshimura S; et al. (Lancet (London, England), 2026)